Aventis Pasteur Limited
TORONTO, CA· latest recorded location
Aventis Pasteur Limited is named on 61 US grants and 20 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 61
- Published applications
- 20
- Inventors
- 75
- Granted in 2026 so far
- 0
- Most recent grant
- 26 Feb 2008
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 9 | 3 |
| 2002 | 22 | 4 |
| 2003 | 15 | 1 |
| 2004 | 7 | 2 |
| 2005 | 4 | 1 |
| 2006 | 2 | 0 |
| 2007 | 1 | 8 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
By publication year.
Technology areas
Share of 81 documents
- A61KMedicines and medical preparations77
- C07KPeptides67
- A61PTherapeutic uses of medicines45
- C12NMicroorganisms or enzymes39
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests17
- Y02ATechnologies for adaptation to climate change15
- C07HSugars9
- G01NInvestigating or analysing materials by determining their chemical or physical properties7
- C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds3
- C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms3
Recent patents
- Chlamydia antigens and corresponding DNA fragments and uses thereof26 Feb 2008US 7,335,370 B2
- Transferrin receptor genes of moraxella10 Jul 2007US 7,241,449 B1
- Co-expression of recombination proteins21 Mar 2006US 7,015,033 B1
- Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particles7 Mar 2006US 7,008,784 B1
- Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease13 Dec 2005US 6,974,581 B1
- Chlamydia antigens and protein vaccine18 Jun 2009US 2009/0155350 A1
- Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics8 Feb 2007US 2007/0031852 A1
- Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics11 Jan 2007US 2007/0009900 A1
- Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics11 Jan 2007US 2007/0009901 A1
- Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics11 Jan 2007US 2007/0009902 A1
Most cited
By later US patents
- Biodegradable targetable microparticle delivery system86US 6,471,996 B12002
- Multi oligosaccharide glycoconjugate bacterial meningitis vaccines30US 6,656,472 B12003
- Lactoferrin receptor protein19US 6,348,198 B12002
- Nucleic acid respiratory syncytial virus vaccines15US 6,486,135 B12002
- Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia14US 6,521,745 B12003